Preventive effects of kefir on colon tumor development in Wistar rats: gut microbiota critical role
Journal of Developmental Origins of Health and Disease · 2025
DOI: 10.1017/s2040174424000461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Developmental Origins of Health and Disease, 2025. Verfasst von Poliana Guiomar de Almeida Brasiel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Kefir, Gastrointestinal Microbiome, Colonic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
To clarify the effects of kefir in critical periods of development in adult diseases, we study the effects of kefir intake during early life on gut microbiota and prevention of colorectal carcinogenesis in adulthood. Lactating Wistar rats were divided into three groups: control (C), kefir lactation (KL), and kefir puberty (KP) groups. The C and KP groups received 1 mL of water/day; KL dams received kefir milk daily (10 8 CFU/mL) during lactation. After weaning (postnatal day 21), KP pups received kefir treatment until 60 days. At 67 days old, colorectal carcinogenesis was induced through intraperitoneal injection of 1, 2-dimethylhydrazine. The gut microbiota composition were analyzed by 16S rRNA gene sequencing and DESeq2 (differential abundance method), revealing significant differences in bacterial abundances between the kefir consumption periods. Maternal kefir intake strong anticancer power, suppressed tumors in adult offspring and reduced the relative risk of offspring tumor development. The gut microbiota in cecal samples of the KL group was enriched with Lactobacillus , Romboutsia , and Blautia . In contrast, control animals were enriched with Acinetobacter . The administration of kefir during critical periods of development, with emphasis on lactation, affected the gut microbial community structure to promote host benefits. Pearson analysis indicated positive correlation between tumor number with IL-1 levels. Therefore, the probiotic fermented food intake in early life may be effective as chemopreventive potential against colon tumor development, especially in lactation period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nutrition, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
- Department of Biology, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
- Department of Clinical Medicine, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
- Department of Parasitology, Microbiology and Immunology, Federal University of Juiz de Fora, Minas Gerais, Brazil.
ORCID-Profile: Poliana Guiomar de Almeida Brasiel
Zitieren
APA
Brasiel, P. G. A., Dutra Medeiros, J., Costa de Almeida, T., Teodoro de Souza, C., de Cássia Ávila Alpino, G., Barbosa Ferreira Machado, A., & Dutra Luquetti, S. C. P. (2025). Preventive effects of kefir on colon tumor development in Wistar rats: gut microbiota critical role. Journal of Developmental Origins of Health and Disease. https://doi.org/10.1017/s2040174424000461
Vancouver
Brasiel PGA, Dutra Medeiros J, Costa de Almeida T, Teodoro de Souza C, de Cássia Ávila Alpino G, Barbosa Ferreira Machado A, et al. Preventive effects of kefir on colon tumor development in Wistar rats: gut microbiota critical role. Journal of Developmental Origins of Health and Disease. 2025. doi:10.1017/s2040174424000461
BibTeX
@article{Brasiel2025,
author = {Brasiel, Poliana Guiomar de Almeida and Dutra Medeiros, Julliane and Costa de Almeida, Thaís and Teodoro de Souza, Claudio and de Cássia Ávila Alpino, Gabriela and Barbosa Ferreira Machado, Alessandra and Dutra Luquetti, Sheila Cristina Potente},
title = {Preventive effects of kefir on colon tumor development in Wistar rats: gut microbiota critical role},
journal = {Journal of Developmental Origins of Health and Disease},
year = {2025},
doi = {10.1017/s2040174424000461}
}
EUVIMED